GentiBio is an emerging biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology from Seattle Children’s Research Institute, Benaroya Research Institute, and MIGAL Galilee Research Institute. GentiBio is focused on the development of EngTregs programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio’s proprietary autologous and allogeneic EngTregs platform integrates key complementary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics.
GentiBio is seeking to build an organization with an exceptional company culture focused on empowerment, care for our team members, an appreciation for diversity and inclusion, and the development of our people. As such, we are looking for candidates who are not just great scientists but individuals who are looking to contribute to building and modeling an outstanding company culture – and having fun while doing so.
GentiBio is building corporate operations in both Boston and Seattle. We are looking for outstanding leaders and scientists to join our team in both of our locations.
GentiBio is seeking a motivated Senior Scientist/Principal Scientist to join our exciting, fast-growing, and well-financed team to develop novel cell therapies for autoimmune diseases. Reporting to the Senior Director of Platform Engineering, the successful candidate will play an integral role in developing GentiBio’s viral vector platform to support production of EngTregs. This role offers exposure to multiple facets of an organizational and company build, leadership and technical growth, and ample opportunities to be a high-impact trailblazer in the emerging field of Treg-cell therapy.
Qualifications and Education Requirements